Nancy S. Nicholson
St. Elizabeth's Medical Center(US)
Publications by Year
Research Areas
Platelet Disorders and Treatments, Antiplatelet Therapy and Cardiovascular Diseases, Cell Adhesion Molecules Research, Heparin-Induced Thrombocytopenia and Thrombosis, Coagulation, Bradykinin, Polyphosphates, and Angioedema
Most-Cited Works
- → Assessment of platelet function assays(1998)162 cited
- → Potent in vitro and in vivo inhibitors of platelet aggregation based upon the Arg-Gly-Asp-Phe sequence of fibrinogen. A proposal on the nature of the binding interaction between the Arg-guanidine of RGDX mimetics and the platelet GP IIb-IIIa receptor(1993)107 cited
- → REGULATORY INFLUENCES OF ADIPOSE TISSUE ON FOOD INTAKE AND BODY WEIGHT*(1965)76 cited
- → Design, Parallel Synthesis, and Crystal Structures of Pyrazinone Antithrombotics as Selective Inhibitors of the Tissue Factor VIIa Complex(2003)71 cited
- → SC-54684A: An Orally Active Inhibitor of Platelet Aggregation(1995)65 cited
- → Pharmacological Interruption of Acute Thrombus Formation with Minimal Hemorrhagic Complications by a Small Molecule Tissue Factor/Factor VIIa Inhibitor: Comparison to Factor Xa and Thrombin Inhibition in a Nonhuman Primate Thrombosis Model(2003)64 cited
- → A New Model of Dual Interacting Ligand Binding Sites on Integrin αIIbβ3(1999)60 cited
- → Structure-based drug design of pyrazinone antithrombotics as selective inhibitors of the tissue factor VIIa complex(2003)42 cited
- → Potent inhibitors of platelet aggregation based upon the Arg-Gly-Asp-Phe sequence of fibrinogen. A proposal on the nature of the binding interaction between the Asp-carboxylate of RGDX mimetics and the platelet GP IIb-IIIa receptor(1992)41 cited
- → In vitro and in vivo effects of a peptide mimetic (SC-47643) of RGD as an antiplatelet and antithrombotic agent(1991)40 cited